Ulrika Joneborg

Publications
Grants
CV
Public outreach and news

Articles

Article: HEMATOLOGY/ONCOLOGY CLINICS OF NORTH AMERICA. 2024;38(6):1173-1190
Epidemiology of Gestational Trophoblastic Disease
Joneborg U
Journal article: ESMO OPEN. 2024;9:103542
82MO European multi-disciplinary tumor boards within the EURACAN network increasingly support management of patients with rare gynaecological tumors: 6-year activity results
Bergamini A; Joneborg U; Marquina G; Grassi E; Wallin E; Herraez AC; Solheim O; Sassu CM; Lok C; Bini M; Pautier P; Kridelka F; Sehouli J; Van Nieuwenhuysen E; Coulter J; Bolze P-A; Lebreton C; Jurgen P; Ray-Coquard IL; Seckl MJ
Article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2024;50(3):108012
Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization
Bolze P; Schoenen S; Margaillan M; Braga A; Sauthier P; Elias K; Seckl M; Winter M; Coulter J; Lok C; Joneborg U; Malinverno MU; Hajri T; Massardier J; You B; Golfier F; Goffin F
Article: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 2024;89(3):214-229
Surgical Management of Gestational Trophoblastic Disease
Coopmans L; Larsson A; Joneborg U; Lok C; van Trommel N
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2023;102(12):1653-1660
Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer
Palsdottir K; Salehi S; Johansson H; Groes-Kofoed N; Falconer H; Joneborg U
Article: NPJ PRECISION ONCOLOGY. 2023;7(1):111
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
Akerlund E; Gudoityte G; Moussaud-Lamodiere E; Lind O; Bwanika HC; Lehti K; Salehi S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U; Seashore-Ludlow B
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023;33(10):1621-1626
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors
Joneborg U; Bergamini A; Wallin E; Mangili G; Solheim O; Marquina G; Casado A; Rokkones E; Coulter J; Lok CAR; van Trommel N; Amant F; Bolze P-A; Sehouli J; Han S; Kridelka F; Goffin F; Pautier P; Ray-Coquard I; Seckl M
Journal article: CANCER RESEARCH. 2022;82(12_Supplement):1890
Abstract 1890: Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
Åkerlund E; Gudoityte G; Lamodiere EM; Carlson J; Wallin E; Fernebro J; Kallioniemi O; Östling P; Joneborg U; Seashore-Ludlow B
Article: CANCERS. 2022;14(3):852
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
Wallin E; Niemann I; Faaborg L; Fokdal L; Joneborg U
Article: CANCERS. 2021;13(14):3604
PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
Ninou AH; Lehto J; Chioureas D; Stigsdotter H; Schelzig K; Akerlund E; Gudoityte G; Joneborg U; Carlson J; Jonkers J; Seashore-Ludlow B; Gustafsson NMS
Article: NATURE COMMUNICATIONS. 2021;12(1):3904
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
Pietilae EA; Gonzalez-Molina J; Moyano-Galceran L; Jamalzadeh S; Zhang K; Lehtinen L; Turunen SP; Martins TA; Gultekin O; Lamminen T; Kaipio K; Joneborg U; Hynninen J; Hietanen S; Grenman S; Lehtonen R; Hautaniemi S; Carpen O; Carlson JW; Lehti K
Article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2021;47(2):353-359
Time-interval to adjuvant chemotherapy and postoperative management after upper abdominal surgical procedures in advanced ovarian cancer
Joneborg U; Palsdottir K; Farm E; Johansson H; Salehi S
Article: ULTRASOUND IN OBSTETRICS AND GYNECOLOGY. 2020;56(5):759-765
Sonographic characteristics of post-molar gestational trophoblastic neoplasia at diagnosis and during follow-up, and relationship with methotrexate resistance
Epstein E; Joneborg U
Article: GYNECOLOGIC ONCOLOGY. 2020;159(1):58-65
Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population
Falconer H; Joneborg U; Krawiec K; Palsdottir K; Bottai M; Salehi S
Article: ACTA ONCOLOGICA. 2020;59(7):760-765
Surgery performed later in the week is associated with failure to achieve complete radical surgical resection in advanced ovarian cancer
Palsdottir K; Joneborg U; Hasselgren E; Johansson H; Salehi S
Article: EUROPEAN JOURNAL OF CANCER. 2020;130:228-240
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease
Lok C; van Tromme N; Massuger L; Golfie F; Seckl M
Article: EMBO MOLECULAR MEDICINE. 2020;12(4):e11177
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
Moyano-Galceran L; Pietila EA; Turunen SP; Corvigno S; Hjerpe E; Bulanova D; Joneborg U; Alkasalias T; Miki Y; Yashiro M; Chernenko A; Jukonen J; Singh M; Dahlstrand H; Carlson JW; Lehti K
Article: CANCER RESEARCH. 2020;80(7):1538-1550
Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
Peuget S; Zhu J; Sanz G; Singh M; Gaetani M; Chen X; Shi Y; Saei AA; Visnes T; Lindstrom MS; Rihani A; Moyano-Galceran L; Carlson JW; Hjerpe E; Joneborg U; Lehti K; Hartman J; Helleday T; Zubarev R; Selivanova G
Journal article: CLINICAL CANCER RESEARCH. 2019;25(22_Supplement):gmm-041-gmm-041
Abstract GMM-041: OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
Moyano-Galceran L; Turunen SP; Pietilä E; Alkasalias T; Corvigno S; Hjerpe E; Joneborg U; Bulanova D; Eriksson M; Dahlstrand H; Carlson J; Lehti K
Article: JOURNAL OF ROBOTIC SURGERY. 2019;13(2):351-353
Iliaco-enteric fistula after robot-assisted comprehensive surgical staging of endometrial cancer: a case report
Salehi S; Daryapeyma A; Suzuki C; Joneborg U; Falconer H
Journal article: ULTRASOUND IN OBSTETRICS AND GYNECOLOGY. 2018;52(S1):112
OP16.03: Sonographic characteristics of postmolar gestational trophoblastic neoplasia (GTN) at diagnosis and during follow‐up
Epstein E; Joneborg U
Journal article: ULTRASOUND IN OBSTETRICS AND GYNECOLOGY. 2018;52(S1):47
OC19.08: Sonographic characteristics of postmolar gestational trophoblastic neoplasia (GTN) in relation to chemo‐resistant disease
Joneborg U; Epstein E
Article: ACTA ONCOLOGICA. 2018;57(8):1094-1099
Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study
Joneborg U; Folkvaljon Y; Papadogiannakis N; Lambe M; Marions L
Article: ACTA ONCOLOGICA. 2018;57(6):820-824
Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging
Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2014;211(6):681.e1-681.e7
Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study
Joneborg U; Eloranta S; Johansson ALV; Marions L; Weibull CE; Lambe M
Article: THE JOURNAL OF REPRODUCTIVE MEDICINE. 2014;59(1-2):51-55
Current Clinical Features of Complete and Partial Hydatidiform Mole in Sweden
Joneborg U; Marions L
Article: THE JOURNAL OF REPRODUCTIVE MEDICINE. 2011;56(11-12):511-514
Choriocarcinoma Following Ovarian Hydatidiform Mole A Case Report
Joneborg U; Papadogiannakis N; Lindell G; Marions L
Article: LAKARTIDNINGEN. 2005;102(16):1247-1250
[Hydatidiform mole and other trophoblastic diseases].
Joneborg U; Marions L
Show more

All other publications

Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024;34:a551-a552
685 European multi-disciplinary tumour boards within the EURACAN network increasingly support management of patients with rare gynaecological tumours: results from 2017–2023 activity
Bergamini A; Joneborg U; Marquina G; Grassi E; Wallin E; Casado A; Solheim O; Sassu CM; Lok CAR; Bini M; Pautier P; Kridelka F; Sehouli J; Van Nieuwenhuysen E; Coulter J; Bolze P-A; Lebreton C; Piek JMJ; Ray-Coquard I; Seckl M
Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023;33:a300.1-a3a300
VOC ANALYSES IN PLASMA SHOW HIGH SENSITIVITY TO DISTINGUISH OVARIAN CANCER PATIENTS FROM HEALTHY CONTROLS
Dobilas A; Radestad AF; Herbst F; Joneborg U; Falconer H; Puglisi D; Eriksson J; Borgfeldt C
Preprint: RESEARCH SQUARE. 2023
The Drug Efficacy Testing in Ex Vivo 3D Cultures (DETECt) platform enables rapid identification of effective drugs and drug combinations for ovarian cancer patients
Seashore-Ludlow B; Åkerlund E; Gudoityte G; Moussaud-Lamodière E; Lind O; Bwanika HC; Lehti K; Saheli S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U
Conference publication: CANCER RESEARCH. 2022;82(12)
Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
Akerlund E; Gudoityte G; Lamodiere EM; Carlson J; Wallin E; Fernebro J; Kallioniemi O; Ostling P; Joneborg U; Seashore-Ludlow B
Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2021;31:A164
EUROPEAN MULTI-DISCIPLINARY TUMOUR BOARDS SUPPORT CROSS-BORDER NETWORKING AND INCREASE TREATMENT OPTIONS FOR PATIENTS WITH RARE TUMOURS
Joneborg U; Bergamini A; Wallin E; Mangili G; Solheim O; Rokkones E; Casado A; Marquina G; Lok C; Van Trommel N; Bolze PA; Coulter J; Pautier P; Goffin F; Han S; Kridelka F; Sehouli J; Amant F; Ray-Coquard I; Seckl M
Conference publication: ANNALS OF ONCOLOGY. 2021;32:S765
Multi-centre study of escalated etoposide/cisplatin (Esc-EP) as a novel salvage regimen in advanced/refractory gestational trophoblastic neoplasia
Clark J; Suyanto S; Hennah L; Winter M; Joneborg U; Wallin E; Harry A; Naban N; Kaur B; Aguiar X; Tin T; Sarwar N; Gonzalez M; Seckl M
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2021;31(3):399-411
Fertility and pregnancy outcome in gestational trophoblastic disease
Joneborg U; Coopmans L; van Trommel N; Seckl M; Lok CAR
Meeting abstract: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29:A475
ANASTOMOTIC BOWEL LEAKAGE AFTER CYTOREDUCTIVE SURGERY IN ADVANCED EPITHELIAL OVARIAN CANCER SURGERY: RELATION TO SURGICAL SPECIALTY AND COMPLEXITY SCORE
Joneborg U; Salehi S; Falconer H; Nilsson PJ; Radestad AF
Meeting abstract: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29:A148
APPLICATION OF ANCILLARY TESTING IN THE DIAGNOSIS OF HYDATIDIFORM MOLE: A COMPARISON OF GENOTYPING AND PLOIDY
Wessman S; Joneborg U; Gurtl-Lackner B; Carlso J
Conference publication: CLINICAL CANCER RESEARCH. 2019;25(22):104
OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
Moyano-Galceran L; Turunen SP; Pietila E; Alkasalias T; Corvigno S; Hjerpe E; Joneborg U; Bulanova D; Eriksson M; Dahlstrand H; Carlson J; Lehti K
Letter: THE LANCET. 2017;390(10110):2343-2345
Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia
Ghorani E; Kaur B; Fisher RA; Short D; Joneborg U; Carlson JW; Akarca A; Marafioti T; Quezada SA; Sarwar N; Seckl MJ
Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):1084
HYDATIDIFORM MOLE AND SUBSEQUENT PREGNANCY OUTCOME: A POPULATION-BASED COHORT STUDY
Joneborg U; Eloranta S; Johansson ALV; Marions L; Weibull CE; Lambe M

Grants

Druging 3D-oids: Molecular subtypes and targeted therapies for ovarian cancer
Swedish Research Council
1 December 2021 - 30 November 2025

Employments

Affiliated to Research, Department of Women's and Children's Health, Karolinska Institutet, 2022-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2016
University Medical Degree, Karolinska Institutet, 1993

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI